Skip to main content
Caplight Logo









Vesper Ventures

Vesper Ventures

Private
BrazilHealthcare & Life Scienceshttps://www.vesper-bio.com/

Last Round

Grant

Nov 1, 2025

Total Funding Raised

$2.55M

Company Overview

Vesper Ventures operates in Healthcare & Life Sciences and is based in Brazil. Its latest recorded funding round was a Grant round in November 2025.

Vesper Ventures is a venture builder and investment firm based in Brazil that focuses on early-stage biotechnology companies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Vesper Ventures Comparables

Compare Vesper Ventures with similar companies based on industry and business-model similarity.

Vesper Ventures comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
The Ganesha Lab
83%
MedXCell SA
83%
Nova BioVentures
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Vesper Ventures Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 1, 2025
Series AOct 31, 2025
SeedApr 8, 2010
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Vesper Ventures Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 8, 2010

    Seed round led by Lundbeckfonden BioCapital.

Book a demo to see all signals

For institutional investors. Book with your work email.

Vesper Ventures Filings

Explore SEC and related filing metadata, where available.

Vesper Ventures filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Vesper Ventures's valuation, stock price, and market status.

Is Vesper Ventures a public or private company?

Vesper Ventures is a private company.

What is the current stock price of Vesper Ventures?

Vesper Ventures is a private company, so its shares have no public market price. Caplight tracks Vesper Ventures's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Vesper Ventures worth (valuation)?

Valuation information for Vesper Ventures is not publicly available.

Can I buy Vesper Ventures stock?

Vesper Ventures shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Vesper Ventures's last funding round?

Vesper Ventures's most recent funding round was Grant on November 1, 2025.

Who are the main investors in Vesper Ventures?

Key investors in Vesper Ventures include Lundbeckfonden BioCapital.

Will Vesper Ventures IPO soon?

No public IPO plans have been announced for Vesper Ventures.

How can I track Vesper Ventures secondary market activity?

Caplight tracks bids, offers, and trades in Vesper Ventures's shares on secondary markets.

Firmographic Details

HeadquartersBrazil
Year Founded2015
Last FundingNov 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?